nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—MAOB—Alzheimer's disease	0.252	0.565	CbGaD
Dopamine—SLC6A4—Alzheimer's disease	0.114	0.255	CbGaD
Dopamine—SLC22A2—Memantine—Alzheimer's disease	0.105	0.315	CbGbCtD
Dopamine—CYP2D6—Alzheimer's disease	0.08	0.18	CbGaD
Dopamine—DRD2—Memantine—Alzheimer's disease	0.0732	0.219	CbGbCtD
Dopamine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0381	0.114	CbGbCtD
Dopamine—CYP2C19—Memantine—Alzheimer's disease	0.0348	0.104	CbGbCtD
Dopamine—CYP2C9—Donepezil—Alzheimer's disease	0.0333	0.0995	CbGbCtD
Dopamine—CYP2D6—Donepezil—Alzheimer's disease	0.0305	0.091	CbGbCtD
Dopamine—CYP2D6—Galantamine—Alzheimer's disease	0.0196	0.0586	CbGbCtD
Dopamine—DBH—locus ceruleus—Alzheimer's disease	0.00975	0.126	CbGeAlD
Dopamine—DRD3—telencephalic ventricle—Alzheimer's disease	0.00379	0.049	CbGeAlD
Dopamine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00371	0.0479	CbGeAlD
Dopamine—HTR7—locus ceruleus—Alzheimer's disease	0.00358	0.0462	CbGeAlD
Dopamine—MAOA—locus ceruleus—Alzheimer's disease	0.00342	0.0442	CbGeAlD
Dopamine—POU5F1—cerebellum—Alzheimer's disease	0.00325	0.042	CbGeAlD
Dopamine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00271	0.0351	CbGeAlD
Dopamine—COMT—telencephalic ventricle—Alzheimer's disease	0.00244	0.0316	CbGeAlD
Dopamine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00218	0.0282	CbGeAlD
Dopamine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00178	0.0229	CbGeAlD
Dopamine—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.00172	0.0602	CcSEcCtD
Dopamine—HTR7—telencephalic ventricle—Alzheimer's disease	0.0017	0.0219	CbGeAlD
Dopamine—Necrosis—Memantine—Alzheimer's disease	0.00163	0.0568	CcSEcCtD
Dopamine—DRD2—telencephalic ventricle—Alzheimer's disease	0.0016	0.0207	CbGeAlD
Dopamine—Masoprocol—IGF1R—Alzheimer's disease	0.00156	0.491	CrCbGaD
Dopamine—Extrasystoles—Memantine—Alzheimer's disease	0.00152	0.053	CcSEcCtD
Dopamine—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00148	0.0518	CcSEcCtD
Dopamine—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00139	0.0485	CcSEcCtD
Dopamine—DBH—forebrain—Alzheimer's disease	0.00121	0.0156	CbGeAlD
Dopamine—DBH—telencephalon—Alzheimer's disease	0.00111	0.0143	CbGeAlD
Dopamine—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00108	0.0376	CcSEcCtD
Dopamine—Atrial fibrillation—Memantine—Alzheimer's disease	0.000977	0.0341	CcSEcCtD
Dopamine—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000956	0.0334	CcSEcCtD
Dopamine—DRD5—forebrain—Alzheimer's disease	0.000928	0.012	CbGeAlD
Dopamine—Bradycardia—Galantamine—Alzheimer's disease	0.000927	0.0324	CcSEcCtD
Dopamine—Angina pectoris—Donepezil—Alzheimer's disease	0.000859	0.03	CcSEcCtD
Dopamine—DRD5—telencephalon—Alzheimer's disease	0.000853	0.011	CbGeAlD
Dopamine—HTR7—blood vessel—Alzheimer's disease	0.00084	0.0108	CbGeAlD
Dopamine—Angina pectoris—Memantine—Alzheimer's disease	0.00078	0.0272	CcSEcCtD
Dopamine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000763	0.0267	CcSEcCtD
Dopamine—Bradycardia—Donepezil—Alzheimer's disease	0.000718	0.0251	CcSEcCtD
Dopamine—DRD1—forebrain—Alzheimer's disease	0.000709	0.00916	CbGeAlD
Dopamine—Palpitations—Galantamine—Alzheimer's disease	0.0007	0.0245	CcSEcCtD
Dopamine—Hypertension—Galantamine—Alzheimer's disease	0.000684	0.0239	CcSEcCtD
Dopamine—Anxiety—Galantamine—Alzheimer's disease	0.000672	0.0235	CcSEcCtD
Dopamine—DBH—nervous system—Alzheimer's disease	0.000655	0.00846	CbGeAlD
Dopamine—Bradycardia—Memantine—Alzheimer's disease	0.000652	0.0228	CcSEcCtD
Dopamine—DRD1—telencephalon—Alzheimer's disease	0.000652	0.00842	CbGeAlD
Dopamine—COMT—forebrain—Alzheimer's disease	0.000638	0.00824	CbGeAlD
Dopamine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000638	0.0223	CcSEcCtD
Dopamine—Tachycardia—Galantamine—Alzheimer's disease	0.000631	0.0221	CcSEcCtD
Dopamine—DBH—central nervous system—Alzheimer's disease	0.000631	0.00815	CbGeAlD
Dopamine—DBH—cerebellum—Alzheimer's disease	0.000617	0.00796	CbGeAlD
Dopamine—SLC22A3—embryo—Alzheimer's disease	0.000606	0.00783	CbGeAlD
Dopamine—COMT—telencephalon—Alzheimer's disease	0.000587	0.00758	CbGeAlD
Dopamine—DRD4—brain—Alzheimer's disease	0.000584	0.00755	CbGeAlD
Dopamine—SLC6A3—forebrain—Alzheimer's disease	0.00057	0.00736	CbGeAlD
Dopamine—SLC22A1—forebrain—Alzheimer's disease	0.000561	0.00725	CbGeAlD
Dopamine—MAOB—embryo—Alzheimer's disease	0.000561	0.00725	CbGeAlD
Dopamine—ADRB1—forebrain—Alzheimer's disease	0.00054	0.00698	CbGeAlD
Dopamine—DRD3—nervous system—Alzheimer's disease	0.000537	0.00694	CbGeAlD
Dopamine—Hypertension—Donepezil—Alzheimer's disease	0.00053	0.0185	CcSEcCtD
Dopamine—SLC6A3—telencephalon—Alzheimer's disease	0.000524	0.00677	CbGeAlD
Dopamine—SLC6A4—forebrain—Alzheimer's disease	0.000522	0.00674	CbGeAlD
Dopamine—Anxiety—Donepezil—Alzheimer's disease	0.000521	0.0182	CcSEcCtD
Dopamine—DRD3—central nervous system—Alzheimer's disease	0.000517	0.00668	CbGeAlD
Dopamine—SLC22A1—telencephalon—Alzheimer's disease	0.000516	0.00666	CbGeAlD
Dopamine—DRD5—nervous system—Alzheimer's disease	0.000504	0.0065	CbGeAlD
Dopamine—DBH—brain—Alzheimer's disease	0.000501	0.00647	CbGeAlD
Dopamine—ADRB1—telencephalon—Alzheimer's disease	0.000497	0.00642	CbGeAlD
Dopamine—MAOB—forebrain—Alzheimer's disease	0.000496	0.00641	CbGeAlD
Dopamine—Palpitations—Memantine—Alzheimer's disease	0.000493	0.0172	CcSEcCtD
Dopamine—DRD5—central nervous system—Alzheimer's disease	0.000485	0.00626	CbGeAlD
Dopamine—Palpitations—Rivastigmine—Alzheimer's disease	0.000482	0.0168	CcSEcCtD
Dopamine—Hypertension—Memantine—Alzheimer's disease	0.000481	0.0168	CcSEcCtD
Dopamine—SLC6A4—telencephalon—Alzheimer's disease	0.00048	0.0062	CbGeAlD
Dopamine—MAOA—embryo—Alzheimer's disease	0.000479	0.00618	CbGeAlD
Dopamine—Anxiety—Memantine—Alzheimer's disease	0.000473	0.0165	CcSEcCtD
Dopamine—Hypertension—Rivastigmine—Alzheimer's disease	0.000471	0.0165	CcSEcCtD
Dopamine—HTR1A—forebrain—Alzheimer's disease	0.000464	0.00599	CbGeAlD
Dopamine—Anxiety—Rivastigmine—Alzheimer's disease	0.000463	0.0162	CcSEcCtD
Dopamine—SLC6A2—forebrain—Alzheimer's disease	0.00046	0.00594	CbGeAlD
Dopamine—MAOB—telencephalon—Alzheimer's disease	0.000456	0.00589	CbGeAlD
Dopamine—Dyspnoea—Donepezil—Alzheimer's disease	0.000447	0.0156	CcSEcCtD
Dopamine—Tachycardia—Memantine—Alzheimer's disease	0.000444	0.0155	CcSEcCtD
Dopamine—HTR7—forebrain—Alzheimer's disease	0.000443	0.00572	CbGeAlD
Dopamine—Mesalazine—MPO—Alzheimer's disease	0.000442	0.139	CrCbGaD
Dopamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000435	0.0152	CcSEcCtD
Dopamine—HTR1A—telencephalon—Alzheimer's disease	0.000426	0.0055	CbGeAlD
Dopamine—MAOA—forebrain—Alzheimer's disease	0.000423	0.00547	CbGeAlD
Dopamine—SLC6A2—telencephalon—Alzheimer's disease	0.000423	0.00546	CbGeAlD
Dopamine—DRD2—forebrain—Alzheimer's disease	0.000419	0.00541	CbGeAlD
Dopamine—Vomiting—Galantamine—Alzheimer's disease	0.000411	0.0144	CcSEcCtD
Dopamine—DRD3—brain—Alzheimer's disease	0.000411	0.00531	CbGeAlD
Dopamine—HTR7—telencephalon—Alzheimer's disease	0.000407	0.00526	CbGeAlD
Dopamine—Dyspnoea—Memantine—Alzheimer's disease	0.000406	0.0142	CcSEcCtD
Dopamine—Headache—Galantamine—Alzheimer's disease	0.000405	0.0142	CcSEcCtD
Dopamine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000397	0.0139	CcSEcCtD
Dopamine—Mesalazine—PPARG—Alzheimer's disease	0.000392	0.124	CrCbGaD
Dopamine—MAOA—telencephalon—Alzheimer's disease	0.000389	0.00503	CbGeAlD
Dopamine—DRD2—telencephalon—Alzheimer's disease	0.000385	0.00497	CbGeAlD
Dopamine—DRD5—brain—Alzheimer's disease	0.000385	0.00497	CbGeAlD
Dopamine—DRD1—nervous system—Alzheimer's disease	0.000385	0.00497	CbGeAlD
Dopamine—Nausea—Galantamine—Alzheimer's disease	0.000384	0.0134	CcSEcCtD
Dopamine—DRD1—central nervous system—Alzheimer's disease	0.000371	0.00479	CbGeAlD
Dopamine—COMT—nervous system—Alzheimer's disease	0.000346	0.00447	CbGeAlD
Dopamine—COMT—central nervous system—Alzheimer's disease	0.000333	0.00431	CbGeAlD
Dopamine—COMT—cerebellum—Alzheimer's disease	0.000326	0.00421	CbGeAlD
Dopamine—Vomiting—Donepezil—Alzheimer's disease	0.000319	0.0111	CcSEcCtD
Dopamine—Headache—Donepezil—Alzheimer's disease	0.000314	0.011	CcSEcCtD
Dopamine—SLC6A3—nervous system—Alzheimer's disease	0.000309	0.00399	CbGeAlD
Dopamine—SLC22A1—nervous system—Alzheimer's disease	0.000305	0.00393	CbGeAlD
Dopamine—SLC6A3—central nervous system—Alzheimer's disease	0.000298	0.00385	CbGeAlD
Dopamine—Nausea—Donepezil—Alzheimer's disease	0.000298	0.0104	CcSEcCtD
Dopamine—DRD1—brain—Alzheimer's disease	0.000294	0.0038	CbGeAlD
Dopamine—ADRB1—nervous system—Alzheimer's disease	0.000293	0.00379	CbGeAlD
Dopamine—SLC22A1—central nervous system—Alzheimer's disease	0.000293	0.00379	CbGeAlD
Dopamine—SLC22A3—nervous system—Alzheimer's disease	0.000291	0.00376	CbGeAlD
Dopamine—SLC6A3—cerebellum—Alzheimer's disease	0.000291	0.00376	CbGeAlD
Dopamine—Mesalazine—PTGS1—Alzheimer's disease	0.00029	0.0913	CrCbGaD
Dopamine—Vomiting—Memantine—Alzheimer's disease	0.000289	0.0101	CcSEcCtD
Dopamine—Headache—Memantine—Alzheimer's disease	0.000285	0.00996	CcSEcCtD
Dopamine—SLC6A4—nervous system—Alzheimer's disease	0.000283	0.00366	CbGeAlD
Dopamine—Vomiting—Rivastigmine—Alzheimer's disease	0.000283	0.00989	CcSEcCtD
Dopamine—ADRB1—central nervous system—Alzheimer's disease	0.000282	0.00365	CbGeAlD
Dopamine—SLC22A3—central nervous system—Alzheimer's disease	0.00028	0.00362	CbGeAlD
Dopamine—Headache—Rivastigmine—Alzheimer's disease	0.000279	0.00975	CcSEcCtD
Dopamine—SLC6A4—central nervous system—Alzheimer's disease	0.000273	0.00352	CbGeAlD
Dopamine—Nausea—Memantine—Alzheimer's disease	0.00027	0.00945	CcSEcCtD
Dopamine—MAOB—nervous system—Alzheimer's disease	0.000269	0.00348	CbGeAlD
Dopamine—COMT—brain—Alzheimer's disease	0.000265	0.00342	CbGeAlD
Dopamine—Nausea—Rivastigmine—Alzheimer's disease	0.000264	0.00924	CcSEcCtD
Dopamine—MAOB—central nervous system—Alzheimer's disease	0.000259	0.00335	CbGeAlD
Dopamine—MAOB—cerebellum—Alzheimer's disease	0.000254	0.00327	CbGeAlD
Dopamine—CYP2D6—forebrain—Alzheimer's disease	0.000252	0.00325	CbGeAlD
Dopamine—HTR1A—nervous system—Alzheimer's disease	0.000252	0.00325	CbGeAlD
Dopamine—SLC6A2—nervous system—Alzheimer's disease	0.00025	0.00322	CbGeAlD
Dopamine—HTR1A—central nervous system—Alzheimer's disease	0.000242	0.00313	CbGeAlD
Dopamine—HTR7—nervous system—Alzheimer's disease	0.00024	0.00311	CbGeAlD
Dopamine—SLC6A2—central nervous system—Alzheimer's disease	0.00024	0.0031	CbGeAlD
Dopamine—HTR1A—cerebellum—Alzheimer's disease	0.000237	0.00306	CbGeAlD
Dopamine—SLC6A3—brain—Alzheimer's disease	0.000236	0.00305	CbGeAlD
Dopamine—SLC22A1—brain—Alzheimer's disease	0.000233	0.00301	CbGeAlD
Dopamine—HTR7—central nervous system—Alzheimer's disease	0.000232	0.00299	CbGeAlD
Dopamine—CYP2D6—telencephalon—Alzheimer's disease	0.000231	0.00299	CbGeAlD
Dopamine—MAOA—nervous system—Alzheimer's disease	0.00023	0.00297	CbGeAlD
Dopamine—DRD2—nervous system—Alzheimer's disease	0.000227	0.00294	CbGeAlD
Dopamine—HTR7—cerebellum—Alzheimer's disease	0.000226	0.00292	CbGeAlD
Dopamine—ADRB1—brain—Alzheimer's disease	0.000224	0.0029	CbGeAlD
Dopamine—SLC22A3—brain—Alzheimer's disease	0.000223	0.00287	CbGeAlD
Dopamine—MAOA—central nervous system—Alzheimer's disease	0.000221	0.00286	CbGeAlD
Dopamine—DRD2—central nervous system—Alzheimer's disease	0.000219	0.00283	CbGeAlD
Dopamine—SLC6A4—brain—Alzheimer's disease	0.000217	0.0028	CbGeAlD
Dopamine—MAOA—cerebellum—Alzheimer's disease	0.000216	0.00279	CbGeAlD
Dopamine—DRD2—cerebellum—Alzheimer's disease	0.000214	0.00276	CbGeAlD
Dopamine—MAOB—brain—Alzheimer's disease	0.000206	0.00266	CbGeAlD
Dopamine—Epinephrine—TNF—Alzheimer's disease	0.000201	0.0632	CrCbGaD
Dopamine—SLC22A5—cerebellum—Alzheimer's disease	0.000199	0.00257	CbGeAlD
Dopamine—HTR1A—brain—Alzheimer's disease	0.000192	0.00248	CbGeAlD
Dopamine—SLC6A2—brain—Alzheimer's disease	0.000191	0.00246	CbGeAlD
Dopamine—HTR7—brain—Alzheimer's disease	0.000184	0.00237	CbGeAlD
Dopamine—MAOA—brain—Alzheimer's disease	0.000176	0.00227	CbGeAlD
Dopamine—DRD2—brain—Alzheimer's disease	0.000174	0.00224	CbGeAlD
Dopamine—Mesalazine—PTGS2—Alzheimer's disease	0.000166	0.0522	CrCbGaD
Dopamine—SLC22A5—brain—Alzheimer's disease	0.000162	0.00209	CbGeAlD
Dopamine—CYP2D6—nervous system—Alzheimer's disease	0.000137	0.00176	CbGeAlD
Dopamine—CYP2D6—central nervous system—Alzheimer's disease	0.000132	0.0017	CbGeAlD
Dopamine—CYP2D6—cerebellum—Alzheimer's disease	0.000129	0.00166	CbGeAlD
Dopamine—L-DOPA—CYP2D6—Alzheimer's disease	0.000125	0.0394	CrCbGaD
Dopamine—CYP2D6—brain—Alzheimer's disease	0.000104	0.00135	CbGeAlD
Dopamine—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	3.69e-06	3.36e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	3.69e-06	3.36e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	3.68e-06	3.34e-05	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—AKT1—Alzheimer's disease	3.67e-06	3.34e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GSK3B—Alzheimer's disease	3.66e-06	3.32e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IGF1—Alzheimer's disease	3.64e-06	3.31e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CASP3—Alzheimer's disease	3.64e-06	3.31e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CALM1—Alzheimer's disease	3.64e-06	3.31e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ESR1—Alzheimer's disease	3.63e-06	3.3e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CREB1—Alzheimer's disease	3.63e-06	3.3e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—APOE—Alzheimer's disease	3.62e-06	3.29e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	3.62e-06	3.29e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL6—Alzheimer's disease	3.61e-06	3.28e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—INS—Alzheimer's disease	3.61e-06	3.28e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	3.59e-06	3.26e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CAV1—Alzheimer's disease	3.59e-06	3.26e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—F2—Alzheimer's disease	3.58e-06	3.26e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ESR1—Alzheimer's disease	3.58e-06	3.25e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	3.58e-06	3.25e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	3.58e-06	3.25e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	3.57e-06	3.24e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCL2—Alzheimer's disease	3.55e-06	3.22e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.55e-06	3.22e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.55e-06	3.22e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—F2—Alzheimer's disease	3.54e-06	3.21e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	3.52e-06	3.19e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.51e-06	3.19e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IGF1—Alzheimer's disease	3.49e-06	3.17e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	3.48e-06	3.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOTCH1—Alzheimer's disease	3.46e-06	3.14e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—NOS3—Alzheimer's disease	3.45e-06	3.13e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	3.43e-06	3.12e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—LPL—Alzheimer's disease	3.42e-06	3.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	3.42e-06	3.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	3.42e-06	3.11e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	3.41e-06	3.1e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	3.39e-06	3.08e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PPARG—Alzheimer's disease	3.39e-06	3.08e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	3.39e-06	3.08e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.35e-06	3.04e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MAPK8—Alzheimer's disease	3.34e-06	3.04e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—AKT1—Alzheimer's disease	3.33e-06	3.03e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	3.33e-06	3.02e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.33e-06	3.02e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—INS—Alzheimer's disease	3.32e-06	3.02e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.32e-06	3.01e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	3.31e-06	3.01e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOS3—Alzheimer's disease	3.3e-06	3e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	3.3e-06	3e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GSK3B—Alzheimer's disease	3.29e-06	2.99e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	3.28e-06	2.98e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	3.27e-06	2.97e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	3.27e-06	2.97e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CREB1—Alzheimer's disease	3.27e-06	2.97e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	3.26e-06	2.96e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GSK3B—Alzheimer's disease	3.25e-06	2.95e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—INS—Alzheimer's disease	3.25e-06	2.95e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	3.24e-06	2.95e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	3.24e-06	2.94e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.24e-06	2.94e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—F2—Alzheimer's disease	3.22e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CREB1—Alzheimer's disease	3.22e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—INS—Alzheimer's disease	3.2e-06	2.91e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.2e-06	2.91e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCL2—Alzheimer's disease	3.19e-06	2.9e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOS3—Alzheimer's disease	3.16e-06	2.87e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PPARG—Alzheimer's disease	3.16e-06	2.87e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	3.15e-06	2.87e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.15e-06	2.87e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCL2—Alzheimer's disease	3.15e-06	2.86e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTGS2—Alzheimer's disease	3.15e-06	2.86e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	3.14e-06	2.85e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	3.14e-06	2.85e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	3.12e-06	2.84e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	3.11e-06	2.83e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IGF1—Alzheimer's disease	3.1e-06	2.82e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—INS—Alzheimer's disease	3.1e-06	2.81e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—Alzheimer's disease	3.09e-06	2.81e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	3.09e-06	2.8e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—F2—Alzheimer's disease	3.08e-06	2.8e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.05e-06	2.77e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.04e-06	2.77e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	3.03e-06	2.76e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	3.03e-06	2.76e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	3.02e-06	2.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.02e-06	2.74e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.97e-06	2.7e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	2.96e-06	2.69e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	2.94e-06	2.67e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—INS—Alzheimer's disease	2.92e-06	2.65e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—NOS3—Alzheimer's disease	2.91e-06	2.65e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	2.88e-06	2.62e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	2.87e-06	2.61e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	2.87e-06	2.61e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	2.87e-06	2.61e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	2.85e-06	2.59e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	2.85e-06	2.59e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	2.84e-06	2.58e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	2.84e-06	2.58e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—Alzheimer's disease	2.83e-06	2.58e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKT1—Alzheimer's disease	2.83e-06	2.57e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.83e-06	2.57e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	2.82e-06	2.57e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.82e-06	2.56e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOS3—Alzheimer's disease	2.81e-06	2.55e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	2.81e-06	2.55e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—Alzheimer's disease	2.81e-06	2.55e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	2.79e-06	2.54e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—Alzheimer's disease	2.79e-06	2.53e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	2.75e-06	2.5e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	2.74e-06	2.49e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—NOS3—Alzheimer's disease	2.72e-06	2.47e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKT1—Alzheimer's disease	2.71e-06	2.46e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—F2—Alzheimer's disease	2.71e-06	2.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	2.7e-06	2.45e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—Alzheimer's disease	2.69e-06	2.44e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—Alzheimer's disease	2.67e-06	2.42e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	2.66e-06	2.42e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—AKT1—Alzheimer's disease	2.66e-06	2.42e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.66e-06	2.42e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.65e-06	2.41e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.62e-06	2.38e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.61e-06	2.37e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.61e-06	2.37e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.6e-06	2.36e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—LPL—Alzheimer's disease	2.6e-06	2.36e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.59e-06	2.35e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.58e-06	2.34e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK8—Alzheimer's disease	2.58e-06	2.34e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	2.57e-06	2.34e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	2.56e-06	2.33e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—AKT1—Alzheimer's disease	2.52e-06	2.29e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.49e-06	2.26e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	2.48e-06	2.26e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	2.47e-06	2.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.47e-06	2.24e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	2.46e-06	2.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.45e-06	2.23e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.45e-06	2.23e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.44e-06	2.22e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.42e-06	2.2e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.41e-06	2.19e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.41e-06	2.19e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.4e-06	2.18e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.39e-06	2.17e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	2.39e-06	2.17e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	2.38e-06	2.16e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.37e-06	2.15e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	2.37e-06	2.15e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.37e-06	2.15e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.34e-06	2.12e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—Alzheimer's disease	2.33e-06	2.12e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	2.28e-06	2.07e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.22e-06	2.02e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.22e-06	2.02e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.22e-06	2.01e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.21e-06	2.01e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.19e-06	1.99e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	2.19e-06	1.99e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	2.19e-06	1.99e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	2.19e-06	1.99e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.18e-06	1.98e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.18e-06	1.98e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	2.17e-06	1.97e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	2.16e-06	1.96e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.16e-06	1.96e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.15e-06	1.95e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.15e-06	1.95e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—Alzheimer's disease	2.14e-06	1.94e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—Alzheimer's disease	2.14e-06	1.94e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.13e-06	1.94e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.1e-06	1.91e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	2.09e-06	1.9e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.08e-06	1.89e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2.07e-06	1.88e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.05e-06	1.86e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	2.02e-06	1.84e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.02e-06	1.84e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.01e-06	1.83e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2e-06	1.82e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	2e-06	1.82e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.99e-06	1.81e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.99e-06	1.81e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.98e-06	1.8e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.98e-06	1.8e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.97e-06	1.79e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.97e-06	1.79e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.91e-06	1.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.91e-06	1.73e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.9e-06	1.72e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.88e-06	1.71e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—INS—Alzheimer's disease	1.86e-06	1.69e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.86e-06	1.69e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.84e-06	1.68e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.84e-06	1.67e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.83e-06	1.66e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.82e-06	1.66e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.81e-06	1.65e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.8e-06	1.63e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.76e-06	1.6e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.74e-06	1.58e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.73e-06	1.57e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.72e-06	1.56e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.71e-06	1.55e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.7e-06	1.55e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.7e-06	1.54e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.7e-06	1.54e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.69e-06	1.54e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.68e-06	1.53e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.68e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.67e-06	1.52e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.65e-06	1.5e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.63e-06	1.48e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.62e-06	1.47e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—Alzheimer's disease	1.58e-06	1.44e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.58e-06	1.43e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.55e-06	1.41e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-06	1.41e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.53e-06	1.39e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.52e-06	1.38e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.5e-06	1.36e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.49e-06	1.36e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.49e-06	1.35e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.48e-06	1.34e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.45e-06	1.32e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.45e-06	1.32e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	1.29e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.42e-06	1.29e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.4e-06	1.27e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.39e-06	1.27e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.37e-06	1.25e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.36e-06	1.24e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	1.34e-06	1.22e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.33e-06	1.21e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.31e-06	1.19e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.29e-06	1.17e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.28e-06	1.16e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.27e-06	1.15e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—Alzheimer's disease	1.25e-06	1.13e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.22e-06	1.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.18e-06	1.07e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	1.06e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.16e-06	1.06e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.13e-06	1.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	9.73e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	9.88e-07	8.98e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	7.5e-07	6.81e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.89e-07	6.26e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	6.83e-07	6.21e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.84e-07	5.31e-06	CbGpPWpGaD
